Comprehensive quantitative profiling of a patient with every chest CT

contextflow offers a comprehensive suite of services for processing chest CT images. Whether you want to create cohorts of similar patients based on image characteristics or predict risk outcomes or treatment response, contextflow can help in the following areas:

  • Objective evaluation of treatment response through lung analysis and anomaly detection
  • Forecast disease progression and treatment efficacy
  • Early detection of non-responders
  • Screening for lung abnormalities in patients with extrapulmonary conditions, such as rheumatic diseases
  • Early detection of significant changes or disease trends 
  • Early adverse effects

Biomarkers for Clinical Trials
Effective clinical trials require precise, objective biomarkers as endpoints that can be evaluated consistently during the trial across both patients and hospital centers. Designed for large-scale batch analysis, ADVANCE Chest CT enables consistent, unbiased evaluation over time from day one.

Treatment Response Tracking
How do you know if your lung cancer treatment plan is working? Quickly and easily view the entire response in one glance with our TIMELINE nodule tracking feature. TIMELINE detects and quantifies lung nodule changes over time for precise and sensitive treatment response assessment. Intuitive color graphs indicate the time-to-double or halve for every detected nodule.

Driving Efficiency
Our AI technology empowers pharmaceutical companies to streamline their research by automatically processing large quantities of data at once and providing results in formats suitable for research. By leveraging our services, you can reduce inter-rater bias in trials and accelerate the evaluation of chest CT scans, ultimately saving valuable time and resources.

Training & Awareness

Using the AI tool as a second opinion in radiological image assessment to identify more patients that need treatment. Discover how contextflow can transform your pharmaceutical research. Get in touch with us today to explore the possibilities of AI-based chest CT image processing for your clinical trials at


I have been following contextflow’s progress practically since the company’s founding, and their traction in the area of chest CT is impressive. Being able to shape clinical decision support tools that myself and colleagues can benefit from in clinical practice is a big motivator. We’re literally shaping the future.

Jacob Visser

Chief Medical Information Officer & Head of Imaging IT and Value-Based Imaging at Erasmus MC

I really like the transparency of contextflow as opposed to other black box AI solutions. It’s designed to support my workflow while leaving the final decision up to me.

Elmar Kotter

Vice Chair and Head of Imaging Informatics at the Department of Radiology at Freiburg University Medical Center

In the world of AI, it’s crucial to use it safely, be clear about what it does, and make ethical choices. This means moving forward with innovation in a responsible way, creating a future that’s both advanced and thoughtful.

Geraldine Dean

MD MSc MRCS FRCR Consultant Radiologist, Artificial Intelligence Lead NHS SW London Imaging Network

For interstitial lung disease, we use contextflow on a daily clinical basis. We now put the major information into the radiology report. And this is what our clinicians expect from us: to be able to quantify the disease and especially to quantify disease progression in order to improve clinical decision making.

Gerlig Widmann

Managing Senior Physician at the University Department of Radiology at the Medical University of Innsbruck

One of the great features of contextflow is the TIMELINE view, which offers the possibility to actually analyse follow-up scans. And that has a lot of value for our clinical practice because patients will return to our practice for follow-up imaging.

Willem Grootjans

Head of the Imaging Services Group at the Department of Radiology, Leiden University Medical Center

I use contextflow in any routine scan performed, for example, for staging, or for other disease evaluation. It helps me a lot to recognize patterns in patients where you’d not expect or where we cannot clearly see the pathology behind it. So it helps us a lot as a double checker.

Lukas Müller

Radiology Resident & Clinician Scientist at the Medical University of Mainz

contextflow is one of the applications that certainly fits radiology’s current needs and can simplify the analysis of complex lung pathology. With the right insights and technology, we can succeed in introducing AI in a very attractive way to radiology departments on a global scale.

Erik Ranschaert

Former President of the European Society of Medical Imaging Informatics (EuSoMII), Radiologist at St. Nikolaus Hospital in Eupen


We’re very interested in using AI to improve the hospital experience for both doctors and patients; contextflow’s use of deep learning, particularly for lung diseases, is exactly the type of technology we want to evaluate. I very much look forward to the results.

Christian Herold

Head of Radiology at Vienna General Hospital


After using and advising several radiology AI software companies, I can say that what contextflow offers is actually the next generation of AI products to support the radiologist, not replace them. Their general approach means they recognize all relevant findings, not just one.

Anand Patel

MD, Chief of Interventional Radiology, Providence Little Company of Mary Medical Centers


We are very interested in using tools based on artificial intelligence like contextflow to support the decision in the diagnostic process based on the image.

Lluís Donoso Bach

President of the International Society of Radiology